Wir arbeiten zusammen, um den Krebs zu überlisten.

Team

Wir glauben an die Kraft der Schwarmintelligen.z, deshalb haben wir eine globale Gemeinschaft von Spitzenmedizinern und -forschern aufgebaut. Der einzige Weg, den Krebs zu überlisten, besteht darin, zusammenzuarbeiten

Führungsteam

Gilles Wainrib, PhD

Co-founder and Chief Scientific Officer

Linkedin

Thomas Clozel, MD

Co-founder and Chief Executive Officer

Linkedin

Jean-Frédéric Petit-Nivard

Chief Commercial Officer

Linkedin

Meriem Sefta

Chief Diagnostics Officer

Linkedin

Joseph Lehár, PhD

SVP Strategy & Business Development

Linkedin

Vassili Soumelis, MD, PhD

Chief Medical Officer

Linkedin

Darius Meadon

Chief Marketing Officer

Linkedin

May Kang Yu

SVP Finance

Linkedin

Anna Huyghues-Despointes

Chief Corporate Development Officer

Linkedin

Hubert Chaperon

Chief Operating Officer

Linkedin

Mariabrisa Olivares

Chief People Officer

Linkedin

Asif Jan

Chief Data Officer

Linkedin

Gilles Wainrib, PhD

Co-founder and Chief Scientific Officer

Linkedin

Thomas Clozel, MD

Co-founder and Chief Executive Officer

Linkedin

Jean-Frédéric Petit-Nivard

Chief Commercial Officer

Linkedin

Meriem Sefta

Chief Diagnostics Officer

Linkedin

Joseph Lehár, PhD

SVP Strategy & Business Development

Linkedin

Vassili Soumelis, MD, PhD

Chief Medical Officer

Linkedin

Darius Meadon

Chief Marketing Officer

Linkedin

May Kang Yu

SVP Finance

Linkedin

Anna Huyghues-Despointes

Chief Corporate Development Officer

Linkedin

Hubert Chaperon

Chief Operating Officer

Linkedin

Mariabrisa Olivares

Chief People Officer

Linkedin

Asif Jan

Chief Data Officer

Linkedin

Wissenschaftlicher Beirat

  • Prof. Miriam Merad, MD, PhD (Chairwoman)

    Direktor des Instituts für Präzisionsimmunologie an der Mount Sinai School of Medicine in New York

    Linkedin

  • Prof. Olivier Elemento, MD, PhD

    Director am Caryl and Israel Englander Institute for Precision Medicine der Cornell University

    Linkedin

  • Prof. Jean-Yves Blay, MD, PhD

    Generaldirektor am Centre Léon Bérard & Unicancer-University Claude Bernard

    Linkedin

  • Assistant Prof. Jakob Nikolas Kather, MD, MSc

    Pathologe am Universitätskrankenhaus Aachen

    Linkedin

  • Prof. Nicolas Girard, MD, PhD

    Leiter des Thorax Institute am Curie Montsouris

    Linkedin

  • Prof. Fabrice André, MD, PhD

    Forscchungsleiter am Gustave Roussy

    Linkedin

  • Roger Stupp, MD

    Leiter der Neuroonkologischen Abteilung und Professor of Neurological Surgery am Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine

    Affiliation

  • Prof. Gilles Salles, MD, PhD

    Leiter des Lymphoma Service am MSKCC

    Linkedin

  • Prof. Shahrokh Shariat, MD

    Leiter der Urologie an der Medizinischen Universität Wien

    Linkedin

  • Prof. Raphaël Rousseau, MD, PhD

    Chief Medical Officer bei Neogene Therapeutics

    Linkedin

Einige unserer Investoren

gvmubadalaf-prime8-roadscathaybpifrancefirstnjf-capitalmacsf

Direktorium

  • Bruno Strigini, PharmD

    Früherer CEO von Novartis Oncology

    Linkedin

  • Thomas Clozel, MD

    Mitbegründer und CEO

    Linkedin

  • Gilles Wainrib, PhD

    Mitbegründer und CSO

    Linkedin

  • Nicole Junkermann

    Gründerin von NJF Holdings

    Linkedin

  • Bruno Raillard

    Partner FRST Capital

    Linkedin

  • Alex Pasteur

    Partner F-Prime Capital

    Linkedin

  • Laurent Higueret, PharmD

    Investment Director, Large Venture Fund BPIFrance

    Linkedin

  • Jacky Abitbol

    Partner Cathay Innovation

    Linkedin

Zana-yellow-shirt